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SUMÁRIO 
 
A isquémia cerebral resulta de um fornecimento insuficiente de sangue ao cérebro, levando 
a uma desregulação no equilíbrio entre a neurotransmissão excitatória/inibitória e 
consequente morte celular por excitotoxicidade. No sistema nervoso central (SNC) a 
regulação deste equilíbrio é determinada principalmente pelo balanço entre a 
neurotransmissão glutamatérgica e GABAérgica e diversos estudos têm mostrado que a 
neurotransmissão glutamatérgica e GABAérgica está aumentada e reduzida, 
respectivamente, nas lesões isquémicas. Ao contrário das alterações na neurotransmissão 
glutamatérgica na isquémia cerebral que têm sido amplamente investigadas, poucos estudos 
têm abordado os mecanismos moleculares que contribuem para as alterações na 
neurotransmissão GABAérgica. Resultados recentes do nosso laboratório, obtidos 
utilizando o modelo de isquémia cerebral baseado na privação de oxigénio e glicose 
(OGD), mostraram que o insulto isquémico induz a desfosforilação e consequente 
internalização dos receptores de GABA do tipo A (GABAAR), contribuindo para a morte 
neuronal. Após a internalização os GABAAR são rapidamente reciclados e voltam para a 
membrana plasmática ou são encaminhados para os lisossomas a fim de serem degradados. 
O rumo que os GABAAR endocitados tomam depende da interacção das subunidades β1-3 
com a proteína associada à huntingtina 1 (HAP1). Estudos anteriores do nosso laboratório 
mostraram que a OGD transitória também reduz a reciclagem e o regresso para a membrana 
plasmática dos GABAAR, e diminui a interacção dos receptores com a proteína HAP1 em 
neurónios do hipocampo em cultura.  
A proteína HAP1 existe em duas isoformas, HAP1-A e HAP1-B, que compartilham a 
mesma região central (aminoácidos 277-445). A HAP1 está associada a microtúbulos e a 
diversos tipos de organelos, incluindo as mitocôndrias, lisossomas e vesículas sinápticas. 
Tendo em consideração estas observações, no presente trabalho investigámos o papel da 
HAP1 na redução da expressão à superfície e reciclagem dos GABAAR em neurónios de 
hipocampo em cultura após OGD. Os resultados obtidos mostram que a exposição 
transitória de neurónios de hipocampo a OGD (90 min) reduz os níveis da proteína HAP1, 
quando testado por western blot duas horas após o insulto isquémico. Este efeito 
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dependente do tempo de incubação, não foi observado em neurónios incubados na presença 
do inibidor das calpaínas MDL28170. A inibição das fosfatases PP1/PP2A com ácido 
ocadáico também diminuiu a redução de HAP1 induzida pela OGD.  
A diminuição dos níveis da proteína HAP1 foi também observada em neurónios corticais 
expostos a OGD, à semelhança dos resultados obtidos em neurónios do hipocampo em 
cultura. Porém, a oclusão transitória da artéria cerebral média (MCAO), um modelo in vivo 
de isquémia cerebral, teve o efeito oposto sobre os níveis da proteína HAP1 no núcleo 
isquémico, localizado na região cortical. Esta discrepância pode ser devida ao efeito do 
insulto isquémico sobre os níveis da proteína Hap1 em células da glia, presentes no tecido 
cerebral mas ausentes nas culturas neuronais. De acordo com essa hipótese, a análise por 
western blot realizada com extractos de células da glia em cultura expostas a 90 min de 
OGD seguido de 12 h de pós-incubação mostraram um aumento dos níveis de proteína 
HAP1. 
Para investigar o papel modulador de HAP1 nas alterações do tráfego dos GABAAR 
induzidas pelo OGD, foram realizadas experiências em culturas de neurónios de hipocampo 
transfectados com as isoformas HAP1-A ou-1B. A sobre-expressão das duas isoformas de 
HAP1, em neurónios de hipocampo em cultura, preveniu a redução da expressão superficial 
da subunidade β3 do GABAAR induzida pela OGD. Este efeito foi devido ao aumento da 
reciclagem da subunidade β3 do receptor GABAAR, como mostrado através do ensaio de 
reciclagem.  
Em resumo, os nossos resultados sugerem que a proteína HAP1 desempenha um papel 
fundamental na redução da neurotransmissão GABAérgica durante a isquémia cerebral. 
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ABSTRACT 
 
Cerebral ischemia is a pathological condition characterized by a reduction of blood flow to 
the brain leading to an imbalance between excitatory and inhibitory neurotransmission and 
consequent neuronal cell death. In the CNS this balance is mostly regulated by glutamate 
and GABA meurotransmitters. Several studies have shown that during an ischemic insult 
the glutamatergic and GABAergic neurotransmission is up- and down-regulated 
respectively. However, few studies have addressed the molecular mechanisms contributing 
to the alterations in GABAergic neurotransmission in brain ischemia. Recent data from our 
laboratory using the oxygen and glucose deprivation (OGD) model of brain ischemia 
showed that the ischemic insult induces the dephosphorylation and consequent 
internalization of GABAA receptors (GABAAR), contributing to the death of cultured 
hippocampal neurons. Following internalization, GABAAR are rapidly recycled back to the 
plasma membrane or targeted for lysosomal degradation. The sorting of endocytosed 
GABAAR depends on the interaction of GABAAR β1-3 subunits with huntingtin-associated 
protein 1 (HAP1). Previous studies from our laboratory also showed that transient OGD 
reduces the recycling of GABAAR back to the plasma membrane and decrease the 
interaction of the receptors with the HAP1 protein in cultured hippocampal neurons.  
HAP1 consists of two isoforms, HAP1-A and HAP1-B, which share the same middle part 
(amino acids 277-445). The protein is associated with microtubules and with various types 
of membranous organelles, including mitochondria, lysosomes and synaptic vesicles. 
Taking into consideration these observations, in the present work we investigated the 
putative role of HAP1 in the reduction of the surface expression and recycling of GABAAR 
in cultured hippocampal neurons subjected to OGD. Our results show that exposure of 
hippocampal neurons to OGD (90 min) downregulates HAP1 protein levels when tested 2 h 
after ischemic insult by western blot analysis. This effect was time dependent and was 
inhibited in the presence of the calpain inhibitor MDL28170. Inhibition of PP1/PP2A 
phosphatases with okadaic acid also reduced the OGD-induced downregulation of HAP1.  
A decrease in HAP1 protein levels was also observed in cortical neurons exposed to OGD, 
but transient middle cerebral artery occlusion (MCAO), an in vivo model of cerebral 
ischemia, had the opposite effect on HAP1 protein levels in the ischemic core located in 
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cortical region. This discrepancy may be due to the effect of the ischemic insult in HAP1 
protein levels in glial cells present in the brain tissue but not in neuronal cultures. 
Accordingly, western blot analysis performed with extracts of cultured glial cells exposed 
to 90 min of OGD followed by 12 h of post-incubation showed an increase of HAP1 
protein levels.  
To investigate the modulatory role of HAP1 in OGD-induced changes in the traffic of 
GABAAR, experiments were performed in cultured hippocampal neurons transfected with 
HAP1-A or -1B isoforms. Overexpression of the two isoforms of HAP1 in cultured 
hippocampal neurons decreased the OGD-induced downregulation of the surface 
expression of GABAAR β3 subunits. This effect was due to the increased recycling of 
GABAAR β3 as shown with receptor recycling assay. Taken together, our results suggest 
that HAP1 protein has a key role in the down-modulation of GABAaergic 
neurotransmission during cerebral ischemia.  
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1.1. CEREBRAL ISCHEMIA  
Stroke is a pathological condition caused by blockage or rupture of a blood vessel. An 
ischemic stroke occurs when a blood vessel supplying blood to the brain becomes blocked, 
for example by a clot. An hemorrhagic stroke occurs when a blood vessel bursts, leaking 
blood into the brain (Figure 1.1). This condition may result from a number of factors 
defined as risk factors (Sacco 1997) that are considered markers for increased stroke risk. 
For example hypertension, smoking, diabetes, high cholesterol, and lack of physical 
activity are defined modifiable risk factors (Prabhakaran and Chong 2014); age, sex and 
race are considered unmodifiable risk factors (Willey et al. 2014). 
 
 
 
Figure 1.1. (A) Blockage of a blood vessel leads ischemic stroke; (B) Bleeding of a blood vessel of 
the brain induces an hemorrhagic stroke. 
 
Cerebral ischemia, caused by insufficient blood supply to the brain, normally resulting from 
an arterial obstruction, leads to a cascade of damaging events in the brain. The severity and 
the extent of the damage depends on the degree and duration of the ischemic event 
(Aronowski et al. 1999; Back 1998; Fisher and Garcia 1996). In cerebral ischemia the 
blood flow can be transiently blocked to the entire brain, resulting in delayed and selective 
neuronal death (global ischemia) (Brillman 1993; Petito et al. 1987; Swain et al. 1993) or, 
alternatively, blood flow can be locally blocked in a temporary or permanent manner, 
injuring a specific area of the brain (focal ischemia) (Figure 1.2). Under the latter 
conditions it is possible to distinguish two different regions within the lesioned area: i) the 
core, corresponding to the center of the stroke that receives essentially no blood supply; this 
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region contains cells that are dependent on the affected blood vessel to obtain oxygen and 
nutrients required for their metabolism; ii) the penumbra, which is the region surrounding 
the core, containing cells that receive a supply of oxygen and nutrients from nearby non-
affected blood vessels, although it is not sufficient to keep the normal metabolic activity 
(Hossmann 1994; Fisher and Garcia 1996). Focal ischemia in humans occurs mainly as a 
consequence of stroke, cerebral hemorrhage, or traumatic brain injury, whereas global 
ischemia is a consequence of cardiac arrest, open-heart surgery, profuse bleeding, or carbon 
monoxide poisoning.  
 
 
 
Figure 1.2. (A) Focal ischemia: temporary or permanent obstruction of local blood supply, injuring 
a specific area of the brain; (B) Global ischemia: blood flow is transiently blocked to the entire 
brain, resulting in delayed and selective neuronal death. 
 
The brain regions that are more vulnerable to ischemic injury are the hippocampal CA1 
area with pyramidal neurons, the dentate gyrus (DG), medium aspiny neurons of the 
striatum, pyramidal neurons in neocortical layers II, V, and VI, and cerebellar Purkinje 
neurons (Crain et al. 1988; Kirino 1982). The molecular mechanisms underlying the cell-
specific pattern of global ischemia-induced neuronal death are not well understood. In order 
to address this question it is important to choose a model of brain ischemia that mimics the 
molecular and cellular mechanisms involved in neuronal damage following stroke in 
humans.  
INTRODUCTION 
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1.1.1. EXPERIMENTAL MODELS OF GLOBAL AND FOCAL ISCHEMIA 
Different models of stroke have been used to study the mechanisms involved in focal and in 
global ischemia, including in vivo and in vitro models described below (Povlsen et al. 
2012). 
 
1.1.1.1. IN VIVO MODELS  
MODELS OF GLOBAL ISCHEMIA 
The most commonly used models of global ischemia are:  
a) the four-vessel occlusion model in rats (4-VO) (Pulsinelli and Buchan 1988). This model 
consists in a permanent occlusion of both vertebral arteries and temporary ligation of the 
two common carotid arteries. In this model neuronal death is mainly restricted to pyramidal 
neurons of the hippocampal CA1 region. 
b) the two-vessel occlusion (2-VO) also known as temporary bilateral common carotid 
occlusion, or BCCO in gerbils (Kirino 1982; Kitagawa et al. 1998) or (less commonly) 
mice (Kitagawa et al. 1998; Oguro et al. 2001). This model consists in a temporary 
occlusion of the common carotid arteries combined with induced systemic hypotension. 
These models induce extensive bilateral forebrain injury (Eklof and Siesjo 1972) and are 
clinically relevant to study global ischemia associated with cardiac arrest in humans. 
 
MODELS OF FOCAL ISCHEMIA 
The models of focal ischemia are the ones that better mimic stroke or cerebral infarction in 
humans (Oguro et al. 2001; Nagasawa and Kogure 1989). With permanent or temporary 
arterial occlusion (proximal or distal), it is possible to induce a necrotic cell death in the 
core region that leads to an irreversible damage. 
The most commonly used model to study focal cerebral ischemia is the middle cerebral 
artery occlusion (MCAO), in which middle cerebral artery is occluded either transiently or 
permanently. The occlusion is induced by ligation of the common carotid and external 
carotid arteries, followed by insertion of a suture into the internal carotid artery at the 
bifurcation of the common carotid and external carotid arteries (Small and Buchan 2000; 
Ginsberg and Busto 1989; Longa et al. 1989). In the MCAO model the blood flow is lower 
INTRODUCTION 
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than 15% in the core region, and drops to less than 40% in the penumbra. Different 
experimental strategies can be used to evaluate the damage in the core region the stroke.  
 
1.1.1.2. IN VITRO MODEL OF GLOBAL ISCHEMIA: OXYGEN AND GLUCOSE 
DEPRIVATION  
The oxygen and glucose deprivation (OGD) is the most commonly used in vitro model to 
study global ischemia (Dawson et al. 1996; Goldberg and Choi 1993). OGD has been 
performed in primary cultures as well as in organotypic slices.  
The most commonly used primary cultures in OGD studies are neurons or glia (Matute et al. 
2002) isolated from different brain regions, such as the neocortex, hippocampus, 
cerebellum and hypothalamus of embryonic or early postnatal rats or mice (Gottron et al. 
1997). Organotypic slices of the hippocampus are also frequently used in this type of 
studies (Newell et al. 1995; Rimvall et al. 1987; Strasser and Fischer 1995).  
Primary cultures of neurons or organotypic slice cultures are usually incubated in a 
deoxygenated and glucose-free medium (OGD) to mimic the interruption of the oxygen and 
nutrient supply to the brain during the ischemic episode. Following the ischemic stimulus 
the cultures are normally incubated in fresh or conditioned culture medium, in an oxygen-
containing atmosphere environment, to simulate the in vivo blood flow reperfusion period. 
Similarly to what happens in in vivo models, OGD induces apoptotic as well as necrotic cell 
death. Despite being an in vitro model and considered a less complete model, the use of cell 
cultures in OGD experiments is a good system to analyze the molecular mechanisms of 
brain ischemia. 
 
1.1.2. ISCHEMIA-INDUCED CELL DEATH: FEATURES AND MECHANISMS 
In the ischemic brain cell death is induced by multiple factors, including a decrease in pH 
and ATP, free radical production by the mitochondrial respiratory chain, increased 
intracellular Na
+
 concentration and membrane depolarization. These processes lead to 
secondary changes, resulting in the activation of damaging processes (Pulsinelli et al. 1982). 
Ischemic neuronal death is commonly considered a long and delayed process. In fact, 
between the insult and the manifestation of cell damage in some cases it may take days or 
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even weeks (Kirino et al. 1984; Du et al. 1996). However, this depends of the intensity and 
duration of the insult, as well as the brain region affected.  
In addition to the multiple mechanisms that contribute to cell death, ischemic injury can 
also induces distinct modes of cell death. The most studied and accepted pathways of 
ischemic cell death are the necrotic and apoptotic cell death. In fact, both in global and 
focal ischemia it is possible to recognize hallmarks of necrotic as well as apoptotic events 
(Choi 1996; Ginsberg and Busto 1989). The hallmarks of necrotic cell death are the 
expansion of endoplasmic reticulum, disaggregation of polyribosomes, selective swelling 
of dendrites, dilation of organelles and intranuclear vacuoles (Kalimo et al. 1977; Kalimo et 
al. 1982). Apoptosis or programmed cell death (PCD) is a result of a series of events 
mediated by a dedicated set of gene products. Apoptotic neurons exhibit characteristic 
morphologic features that differentiate them from necrotic neurons, including cytoplasmic 
shrinkage, chromatin condensation and apoptotic bodies (Radi et al. 2014).  
In general it is thought that in the initial periods of reperfusion there is the prevalence of 
necrotic markers due to immediate energy failure. Given that apoptotic cell death needs 
energy for cellular modifications such as cytoskeletal proteolysis and DNA alteration (Roy 
and Sapolsky 1999), its hallmarks appear later when mitochondrial physiology alterations 
occur. 
The depletion of energy stores following an ischemic episode induces an ionic imbalance 
leading to increased neurotransmitter release and inhibition of the Na
+
-dependent reuptake 
mechanisms. In particular the deregulation of glutamate and its receptors play an important 
role in the ischemic pathophysiology in different ways (Michaelis 1998). First, the 
increased binding of glutamate to ionotropic NMDA receptors and reduction of calcium 
impermeable subunit of AMPA receptors increase the influx of Ca
2+
 (Pellegrini-Giampietro 
et al. 1999) and the consequent [Ca
2+
]i overload leads to the downstream activation of 
proteases that degrade membrane proteins, including phospholipases and proteases, 
inhibition of ATP production and also an increase of intracellular glutamate, thus, 
propagating the excitotoxic injury (Lo et al. 2003). In addition, ionotropic glutamate 
receptors promote an excessive influx of Na
+ 
with concomitant cell swelling and edema. 
Glutamate-induced neuronal cell death is associated with apoptosis, as evidenced by 
characteristic fragmentation of DNA, morphological changes, activation of calpains and 
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induction of caspase-dependent and -independent mechanisms (Strasser and Fischer 1995; 
Jover et al. 2002; MacManus et al. 1993). However, excessive stimulation with glutamate 
was shown to trigger necrotic cell death (Ankarcrona et al. 1995). In addition to the [Ca
2+
]i 
dysregulation, the alterations in the homeostasis of other ions is also critical upon ischemia. 
For example, Zn
2+
 is an essential cofactor for many enzymes and transcription factors and 
its intracellular accumulation after cerebral ischemia is deleterious for the cells by affecting 
mitochondrial function and consequently inducing cell swelling and production of reactive 
oxygen species (ROS) by mitochondria (Weiss et al. 2000; Dineley et al. 2005; Lewen et al. 
2000; Jiang et al. 2001).   
ROS including the superoxide anion (O
2−
), the hydroxyl radical (OH), hydrogen peroxide 
(H2O2), are particularly responsible for oxidative stress. After ischemia, particularly during 
the reperfusion period, the oxygen radical production and oxidative stress facilitate 
mitochondrial transition pore (MTP) formation. This process dissipates the proton gradient 
required for oxidative phosphorylation and ATP generation (Kroemer and Reed 2000). 
Oxidative stress has been shown to activate several intracellular signaling cascades that 
may have deleterious effects on the cellular homeostasis, such as activation of mitogen-
activated protein kinases (MAPKs) (Cao et al. 2005). In addition to those already known, 
several other targets need to be identified and explored for the development of future 
therapeutic strategies in the brain ischemia field.  
 
1.2. GABA MEDIATED NEUROTRANSMISSION 
In the Central Nervous System (CNS), synaptic transmission is predominantly mediated by 
the neurotransmitters glutamate and γ-aminobutyric acid (GABA) (Bloom and Iversen 
1971), which have an excitatory and inhibitory action, respectively. This work is focused 
on the neurotransmission by GABA which is considered the major inhibitory 
neurotransmitter of the CNS.  
GABA is produced from glutamate by the cytosolic enzyme glutamic acid decarboxylase 
(GAD) and is stored inside small synaptic vesicles by a mechanism dependent on the 
activity of the vesicular inhibitory amino acid transporters. The neurotransmitter GABA is 
exocytosed into synaptic cleft and exerts its inhibitory control by acting on two classes of 
receptors with distinct electrophysiological and pharmacological properties: GABA type A 
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receptors (GABAAR) (Macdonald and Olsen 1994; Wu and Sun 2014; Boue-Grabot et al. 
1998) and GABA type B receptors (GABABR). GABAAR are ionotropic fast-acting ligand-
gated chloride channels (Sieghart 2006) while GABABR are metabotropic G protein-
coupled receptors (Bettler and Tiao 2006) (Figure 1.3). Activation of GABAAR leads to the 
entrance of chloride into the cell according to the concentration gradient, causing 
membrane hyperpolarization.  
GABABR are responsible for the late and slower component of inhibitory synaptic 
transmission (Bettler and Tiao 2006). Their activation induces intracellular signal cascades 
that produce hyperpolarization in postsynaptic membrane and modulate neurotransmitter 
release in presynaptic neurons. The effects of GABABR are typically mediated by 
activation of G-proteins coupled to the inhibition of adenylyl cyclase or voltage-gated Ca
2+
 
channels, and activation of inward rectifying K
+ 
 channels (Couve et al. 2000; Benke 2013). 
Inhibitory synapses exert a strong control on the neuronal response by modulating neuronal 
activity induced by excitatory neurotransmission. 
 
 
Figure 1.3. Schematic representation of a GABAergic synapse. GABA is synthesized in 
inhibitory neurons by glutamate decarboxylation performed by the enzyme glutamic acid 
decarboxylase (GAD), and is transported into synaptic vesicles by a vesicular neurotransmitter 
transporter (VGAT). GABA can be released both by exocytosis or by reversal of the plasma 
membrane transporters. GABA can acts through the activation of different classes of receptors: 
GABAA and GABAB receptors. GABAAR are pentameric receptors associated to chloride channel. 
GABAB receptors are metabotropic receptors that cause presynaptic inhibition by suppressing 
calcium influx. GABA reuptake by surrounding neurons and glia occurs through the activity of 
plasma membrane GABA transporters (GAT).   
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1.2.1. GABAAR STRUCTURE AND FUNCTION  
As mentioned above GABA is the major inhibitory neurotransmitter in the CNS, and its 
fast inhibitory control is mediated by GABAAR which belong to the ionotropic family of 
neurotransmitter receptors (Sieghart 2006). Different gene products contribute to the 
formation of the GABAAR heteropentameric chloride channel, and the diversity of  
GABAAR is further increased by alternative splicing. The studies performed in mammals 
identified 19 genes encoding GABAAR subunits (α1–α6, β1–β3, γ1–γ3, δ, ε, τ, π, ρ1– ρ3), 
and most receptors belonging to this class are formed by the assembly of 2α and 2β 
subunits together with a single γ2 or δ subunit. In fact, the majority of GABAAR in brain 
are composed of α1β2γ2 subunits, followed by α2β3γ2 and α3β2γ2 (Knight et al. 2000; 
Massaria et al. 1976; Chang et al. 1996; Tretter et al. 1997; Luscher et al. 2011). 
The different composition in subunits is the major determinant of the ligand binding and 
gating properties of the GABAAR channels. The precise subcellular localization of different 
GABAAR subtypes and the difference in subunit composition between synaptic and 
extrasynaptic receptors are reflected in a differential modulation of phasic and tonic 
signaling. Moreover depending on the subunit composition GABAAR have also different 
physiological and pharmacological properties. 
Each GABAAR subunit present a structure characterized by an extracellular N-terminal 
domain that is also the site of action of various drugs, four hydrophobic transmembrane 
domains (TM1-4) and an extended cytoplasmic loop region (ICD) between TM3 and TM4 
that mediates the interaction with trafficking and signaling factors and is subject to a 
number of posttranslational modifications. The C-terminal region of GABAAR subunits is 
extracellular (Sieghart 2006). 
It is well established that GABAAR functions and synaptic strength are influenced by the 
number of postsynaptic receptors. The density of surface GABAAR, and in particular the 
number of synaptic receptors, is determined by the balance between the rate of receptor 
exo- and endocytosis, to and from the membrane surface respectively (Belelli et al. 2009) 
(Brickley and Mody 2012), as well as by the lateral diffusion of receptors from and into the 
synaptic region. 
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1.2.2. TRAFFICKING OF GABAAR 
GABAAR are assembled upon oligomerization of the receptor subunits in the endoplasmic 
reticulum (ER). The receptors exit the ER only when the proteins are correctly folded, and 
the misfolded or unassembled receptor subunits are targeted for proteasomal degradation 
(Kittler et al. 2002). This process is negatively regulated by Plic-1, which binds to receptor 
α- and β-subunits and may also increase subunit maturation and production (Saliba et al. 
2008). Following the assembly, GABAAR are transported to the Golgi apparatus where 
they bind the GABARAP/NSF complex. The receptors are then incorporated in vesicles 
and transported to the plasma membrane (Chen et al. 2000; Everitt et al. 2004). 
GABAAR surface expression is very dynamic and regulated. Once in the membrane they 
can reach the postsynaptic region through lateral diffusion, and the synaptic receptors may 
be stabilized by interacting with its scaffold protein gephyrin. When localized in extra 
synaptic compartment the receptors can be removed from the plasma membrane by 
clathrin- and dynamin-dependent endocytosis. This process is facilitated by interactions of 
the GABAAR β and γ subunits intracellular domains with the clathrin adaptor protein AP2 
(Kittler et al. 2000; Kittler et al. 2005; Kittler et al. 2008). This process is negatively 
regulated by phosphorylation, and therefore GABAAR are internalized when they are 
dephosphorylated (Kittler et al. 2005). The efficient endocytosis of GABAAR requires a di-
leucin motif present in the intracellular loop region of the β subunit (Herring et al. 2003; 
Herring et al. 2005). Especially important for AP2/clathrin/dynamin-mediated GABAAR 
internalization in neurons is an amino acid sequence motif that includes a major 
phosphorylation site in the cytoplasmic loop region of β1-3 subunits (S408/409) and the γ2 
subunit (Y365/367). The interaction between AP2 and β1-3/γ2 subunits can be regulated 
both by protein kinase A (PKA) and protein kinase C (PKC) while the same interaction 
with β2 subunit is regulated only by PKC (Kittler et al. 2005; Kittler et al. 2008). 
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1.3. HAP1 AND ITS ROLE IN GABAAR TRAFFICKING 
1.3.1. HAP1 – STRUCTURE, FUNCTION AND LOCALIZATION 
Huntingtin-associated protein-1 (HAP-1) was initially identified using the yeast two-hybrid 
system as an interacting partner for huntingtin (htt), the protein encoded by the Huntington 
disease (HD) gene (Li et al. 1995). Three transcripts that differ for their 3’-end (hap1A, 1B, 
and 1C) are expressed from the mouse hap1 gene due to alternative splicing but only two 
distinct protein isoforms (HAP-1A and HAP-1B) are encoded (Bertaux et al. 1998; 
Dragatsis et al. 2000). These two isoforms, HAP1-A (75 kDa) and HAP1-B (85 kDa), are 
different for their short C-terminal sequences (amino acids 579–599 of HAP1-A versus 
amino acids 579–629 of HAP1-B) and their localization in the brain (Gutekunst et al. 1998; 
Li et al. 1998a). 
HAP1 contains coiled-coil domains in the middle region and multiple N-myristoylation 
sites. Coiled-coil domains and N-myristoylation sites are present in a large number of 
proteins that are associated with membrane-associated proteins and involved in vesicular 
trafficking. HAP1 does not contain transmembrane domains and nuclear localization 
signals, suggesting its cytoplasmic localization. It was also shown that the middle region of 
HAP1 (amino acids 277-445), which is present in both HAP1-A and HAP1-B isoforms, is 
responsible for the self-association (Figure 1.4). Moreover, this region also interacts with 
N-terminus of htt suggesting a role in the interaction of HAP1 with htt (Li et al. 1998a). 
 
 
Figure 1.4. Schematic diagram of the two isoforms of HAP1: HAP1-B (85 kDa) and HAP1-A 
(75 kDa). rHAP1-A and rHAP1-B were isolated from rat brain cDNA libraries. The two isoforms 
have identical sequences in the overlapping regions, with different amino acids in the carboxy-
terminus.  
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HAP1 is expressed in the olfactory bulb, hypothalamus, brain stem, striatum, cerebellum, 
hippocampus and colliculi of mouse and rat, as detected by northern blot and in situ 
hybridization analyses (Li et al. 1995; Bertaux et al. 1998; Dragatsis et al. 2000; Page et al. 
1998). Expression of HAP1 has also been demonstrated in human different brain regions, 
including the amygdala, caudate nucleus, corpus callosum, substantia nigra, subthalamic 
nucleus and thalamus (Li et al. 1998c). So far hap1 transcripts have been associated with 
neurons and not glia (Li et al. 1996). Immunoblotting and immunohistochemistry studies 
have confirmed the expression of HAP1 protein in several regions of the central nervous 
system (CNS) (Li et al. 1995; Martin et al. 1999). During mouse development, hap1 
transcripts are detected in the neuroepithelium, starting from the embryonic day 8.5 (E8.5), 
and are abundantly expressed in the hypothalamus, superior colliculus and cerebellum by 
E17.5 (Dragatsis et al. 2000). Furthermore, the two isoforms of HAP1 were found to be 
differently distributed. In developing hippocampal neurons in culture, HAP1-A 
immunoreactive puncta appear prevalently in neuronal processes, whereas HAP1-B 
staining remains diffuse (Li et al. 2000). In mature neurons (15 days), the majority of 
HAP1-A is concentrated in synaptic structures, in contrast with the majority of HAP1-B 
which remained diffuse in the cytoplasm and neurites (Li et al. 2000). In older neurons 
(>15 days) HAP1-A is highly expressed in axonal regions that might be in contact with 
dendrites, but the expression in dendrites is reduced when compared to younger neurons (Li 
et al. 2000). Studies performed in mice showed that HAP1 expression is not restricted to 
the brain, and the protein was found to be present at high levels in testis and at lower levels 
in lung and spleen. Furthermore, a differential expression of the two isoforms was also 
detected in these regions (Bertaux et al. 1998). 
The molecular function of HAP1 is not completely understood. However, HAP1 has a 
crucial role in the regulation of rodent postnatal feeding behaviour. In fact, mice with 
homozygous disruption at the hap1 locus displayed normal brain and organ structure at 
birth, but showed decreased body weights. Interestingly, hap1
-/-
 pups did not grow after 
birth and die around the 9
th
 postnatal day due to decreased feeding (Chan et al. 2002). This 
phenotype may be caused by the degeneration of hypothalamic neurons that control feeding 
behaviour. Indeed, several lines of evidence suggest that HAP1 is involved in different 
cellular processes including vesicular transport, possibly along microtubules, and neuronal 
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transport of organelles and molecules. The role of HAP1 in intracellular trafficking was 
suggested by its interaction with proteins associated with microtubules. More specifically, 
HAP1 binds p150glued, a dynactin subunit that mediates the interaction of the motor 
protein dynein with microtubules (Li et al. 1998b; Engelender et al. 1997), thereby 
collaborating in the retrograde transport in neurons (McGuire et al. 2006). Furthermore, 
HAP1 also interacts with Duo (alternatively named P-CIP10 or Kalirin-7), a brain specific 
rac1 guanyl-nucleotide exchange factor that binds postsynaptic density-associated proteins 
(Colomer et al. 1997; Penzes et al. 2001).  
The molecular functions of HAP1 are correlated with its subcellular localization. HAP1 has 
been observed to be associated with crude synaptic vesicles (Li et al. 1996; Engelender et al. 
1997), and co-sediments with polymerized endogenous microtubules. Immunocytochemical 
studies indicated that HAP1 is primarily found in the cytoplasm of neurons within punctate 
structures (Li et al. 1996; Martin et al. 1999; Li et al. 1998b). This evidence was confirmed 
using electron microscopy, which showed HAP1 cytoplasmic localization and its 
association with axon terminals and post-synaptic dendritic spines (Gutekunst et al. 1998; 
Martin et al. 1999). Studies performed in PC12 cells transfected with HAP1-A also showed 
that this protein promotes neurite extension, suggesting an additional role in neuronal 
differentiation (Li et al. 2000). Nevertheless the precise function of HAP1 and its role in 
neuronal dysfunction remains to be elucidated, being this protein a possible contributor in 
different pathologies. 
 
1.3.2. THE ROLE OF HAP1 IN GABAAR TRAFFICKING  
After endocytosis GABAAR are targeted for lysosomal degradation or rapidly recycled 
back to the cell surface (Kittler and Moss 2003; Barnes 2000). It was shown that during 
short intervals the majority of internalized GABAAR are rapidly recycled back to the cell 
surface, but after longer periods of time the receptors are degraded. The degradation of 
GABAAR occur in lysosomes, and this was demonstrated in studies showing a reduction of 
receptor degradation in the presence of the lysosomal protease inhibitor leupeptin (Kittler et 
al. 2004). Blocking lysosomal activity or disrupting the trafficking of ubiquitinated cargo to 
lysosomes was shown to  increase the accumulation of GABAAR at synapses with a 
consequent increase of GABAergic inhibition.  
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Previous studies  provide evidence that a direct interaction of GABAAR with HAP1 might 
be involved in the endocytic receptor sorting under physiological condition (Kittler et al. 
2004). HAP1 inhibits degradation of GABAAR and facilitates receptor recycling. 
Furthermore, HAP1 overexpression in cultured neurons showed an increase recycling of 
GABAARs to the cell surface (Kittler et al. 2004). Y2H screen of a rat hippocampal library 
showed  that rat HAP1 interacts specifically with β1-subunit intracellular domain of 
GABAAR (Bedford et al. 2001; Couve et al. 2000). This strong interaction was confirmed 
through pull-down assay and immunoprecipitation, identifying an intracellular domain of 
the protein HAP1 (residues 220-520) that interact with GABAAR (Kittler et al. 2004). 
Another piece of evidence suggesting a role for HAP1 in the intracellular fate of GABAAR 
was the co-localization of HAP1 with clathrin-coated vesicles (Li et al. 2002). Furthermore, 
HAP1 overexpression was shown to increase the surface levels of GABAAR and the 
miniature inhibitory post-synaptic currents (mIPSC) amplitude (Kittler et al. 2004). 
 
1.4. EFFECTS OF ISCHEMIA ON GABA NEUROTRASMISSION  
The reduction of blood flow that characterizes cerebral ischemia induces an imbalance 
between excitatory/inhibitory neurotransmission that is one of the major causes of 
excitotoxic neuronal death. The changes in metabolism associated to an insufficient energy 
supply to the brain induce the extracellular accumulation of glutamate (see section 1.1.2.) 
with the consequent overactivation of excitatory synapses. Under these conditions there are 
also pre- and post-synaptic alterations in GABAergic synapses. One of the early alterations 
occurring at inhibitory synapses upon an ischemic insult is the transient accumulation of 
GABA in the extracellular space which increases GABA-mediated neurotransmission 
(Hutchinson et al. 2002). This event is possibly caused by an increased Ca
2+
-dependent 
release of GABA, as well by reversal of GABA transporters induced by plasma membrane 
depolarization with consequent changes in the Na
+
 electrochemical gradient (Bazan 1970; 
Phillis et al. 1994). 
Important also are the effects on GABAAR and the reduction of their activity. There are 
evidences in vivo that after transient cerebral ischemia GABAA receptors are down-
regulated in regions such as the hippocampus and cerebral cortex, within 30 min of the 
reperfusion onset (Alicke and Schwartz-Bloom 1995). This down-regulation may result 
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from receptor internalization, but the cell surface density of GABAAR returns to normal 
within 2 h after ischemia. It was also shown that together with the down-regulation of 
GABAAR, there is a very rapid decrease of the mRNA for α1 and β3 GABAAR subunits in 
the CA1 and CA3 hippocampal areas, as well as in the dentate gyrus (Li et al. 1993).  
Exposure of cultured hippocampal neurons to oxygen and glucose deprivation (OGD), in 
vitro model of global ischemia, was used to examine molecular changes in GABAergic 
neurotrasmission. Previous results from our laboratory (Mele et al. 2014) established that in 
cultured hippocampal neurons subjected to 90 minutes of OGD there is a down-regulation 
of the GABAAR subunits α1, α2, β3, and γ2 when measured 8h after the stimulus. 
Moreover, western blot analysis using a phosphospecific antibody against serine residues 
408/409 [which are the major sites of phosphorylation for PKA (protein kinase A)] showed 
that OGD reduces the phosphorylation of GABAAR β3 subunit by a mechanism sensitive to 
okadaic acid. Furthermore, transfection of hippocampal neurons with a phospho‐mimetic 
mutant of the GABAAR β3 subunit (SS432/433AA) (homologous of mouse 408/409) 
showed an accumulation of the receptors at cell surface due to the reduction of the OGD‐
induced internalization. This mechanism also protected neurons from OGD-induced cell 
death (Mele et al. 2014). 
 
1.5. OGD-INDUCED ALTEREATION OF GABAAR Β3 RECYCLING AND 
ITS INTERACTION WITH HAP1 
Previous results from our laboratory (Mele et al. 2014) uncovered the molecular 
mechanisms underlying GABAAR downregulation in cultured hippocampal neurons 
subjected to the OGD in vitro model of brain ischemia. Transient exposure of hippocampal 
neurons to OGD also down-regulated the total protein levels of GABAAR subunits (see 
previous section) by a mechanism dependent on the activity of calpains. Moreover, it was 
found that OGD i) decreases GABAAR/Gephyrin interaction, ii) induces the internalization 
of GABAAR via clathrin-dependent endocytosis, iii) reduces the recycling of GABAAR 
back to the plasma membrane and iv) decreases their interaction with the HAP1 protein. 
Based on these observations a new model was proposed to explain the key steps in 
GABAergic down-modulation during cerebral ischemia (Figure 1.5). According to this 
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model, the increase in GABAAR internalization in brain ischemia is followed by a decrease 
in recycling, possibly due to a reduction in the interaction with the HAP1 protein. 
 
 
 
 
FIGURE 1.5. Model of the alteration in GABAAR trafficking during cerebral ischemia (Mele 
et al. 2014).  
The strength of inhibitory synapses is determined by the postsynaptic GABAAR receptor pool size 
which is regulated by their stabilization on the membrane surface and their trafficking between the 
plasma membrane and intracellular compartment. Ischemic insult (1) overactivates NMDAR 
signalling (2) and the resulting stimulation of calcineurin decreases GABAAR/Gephyrin interaction 
(3). In parallel, OGD reduces phosphorylation of GABAAR β3 subunit by a mechanism sensitive to 
okadaic acid (4), inducing the internalization of GABAAR via clathrin dependent endocytosis (5, 6). 
OGD also reduces GABAAR/HAP1 interaction and GABAAR recycling rate (7, 8), driving 
GABAAR to degradation. 
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OBJECTIVES 
The insufficient blood supply to the brain that characterize cerebral ischemia causes an 
imbalance between excitatory/inhibitory neurotransmission and excitotoxic neuronal death. 
GABAA receptors (GABAAR) are the major mediators of inhibitory neurotransmission in 
the CNS and play an essential role in maintaining this balance, required for the correct 
function of neuronal networks (Smith and Kittler 2010).  
The strength of inhibitory synapses is determined by the postsynaptic GABAAR receptor 
pool size which is regulated by their stabilization on the membrane surface and their 
trafficking between the plasma membrane and intracellular compartment. The number of 
plasma membrane receptors is mostly determined by the processes of internalization from 
plasma membrane (Kittler et al. 2000), and recycling to the surface. The GABAAR 
recycling is regulated by their interaction with the HAP1 cytoplasmic protein (Kittler et al. 
2004).  
The exposure of hippocampal neurons to OGD, an in vitro model of cerebral ischemia, was 
shown to increase the internalization of GABAAR via clathrin dependent endocytosis, and 
to reduce the recycling of GABAAR back to the plasma membrane, in addition to 
decreasing their interaction with the HAP1 protein (Mele et al. 2014). The major aim of this 
work was to investigate the role of the HAP1 protein on the alteration of GABAAR 
trafficking in cerebral ischemia. More specifically we investigated the effect of transient 
ischemia on: 
 the total protein levels of HAP1 in hippocampal neurons, cortical neurons and glial 
cells subjected to OGD; The role of calpains and phosphatases in the alterations of 
HAP1 total protein levels was also investigated; 
 
 the alterations in total HAP1 protein levels in the MCAO in vivo model of focal 
bran ischemia;  
 
  the expression of HAP1 mRNA levels in glial cells exposed to OGD; 
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 the effects of HAP1 overexpression on the OGD-induced alteration of surface 
GABAAR and their recycling in cultured hippocampal neurons 
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The antibodies and other reagents used in this work are listed in Tables 2.1 and 2.2. 
 
Table 2.1. List of antibodies used in this work. 
ANTIBODIES 
Name Used dilution Supplier 
 Western Blot  Immunocytochemistry  
anti-Calpastatin 1:200  Santa Cruz Biotechnology 
anti-Chicken IgG conjugated 
with AMCA Fluor 350 
 1:200 Invitrogen 
anti-GFAP   1:1000 NeuroMab 
anti-GFP (rabbit) 1: 500 1:1000 MBL 
anti-HAP1 1:750 1:250 Santa Cruz Biotechnology 
anti-MAP2  1:10000 Abcam 
anti-mouse IgG conjugated 
with Alexa Flour 488 
 1:500 Invitrogen 
anti-mouse IgG conjugated 
with Alexa Flour 568 
 1:500 Invitrogen 
anti-Synaptophysin 1:20000  Abcam 
anti-β-tubulin 1:300000  Sigma-Aldrich 
goat Alexa Flour Far-red 647 
anti-mouse 
 1:500 Invitrogen 
 
 
Table 2.2. List of reagents used in this work.  
REAGENTS 
Name Supplier 
FDU Sigma-Aldrich 
Actynomicin D  Calbiochem 
Antipain Sigma-Aldrich 
Bromophenol blue Merk 
BSA Enzytech or Sigma-Aldrich 
CaCl Panreac 
Chloroform Fisher-Scientific 
Cyclosporin A Santa Cruz Biotechnology 
DAKO Denmark 
DOC Sigma-Aldrich 
DMSO Sigma-Aldrich 
DMEM  Sigma-Aldrich 
DTT Enzytech 
ECF GE Healthcare 
EDTA Sigma-Aldrich 
EGTA Sigma-Aldrich 
Ethanol Fisher-Scientific 
Experion RNA StdSens 
Analysis Kit  
Bio-Rad 
Fetal bovine serum  Invitrogen 
Forskolin Tocris Bioscience 
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Gentamycin Invitrogen 
Glucose VWR Chemicals Prolabo 
Glutamate Sigma-Aldirch 
Glutamine Sigma-Aldrich 
Glycerol Amresco 
HEPES Fisher-Scientific 
Horse serum Invitrogen 
iScript cDNA synthesis kit Bio-Rad 
Isopropanol Panreac 
KCl Panreac quimica S.A.U 
KH2PO4 Panreac quimica S.A.U 
Kynurenic acid Sigma-Aldrich 
Leupeptin Sigma-Aldrich 
MDL28170 Calbiochem 
MEM  Sigma-Aldrich 
MgSO4 Merck 
Na2HPO4.2H2O Merck 
NaCl Panreac quimica S.A.U 
NaF Sigma-Aldrich 
NaHCO3 Merck 
Neurobasal medium  Invitrogen 
Okadaic acid  Santa Cruz Biotechnology 
PenStrep  Invitrogen 
Pepstatin Sigma-Aldrich 
Phenol red Sigma-Aldrich 
PMA Biomol, as part of Enzo Life 
Sciences 
PMSF Sigma-Aldrich 
PVDF membranes Millipore 
Pyruvic acid  Sigma-Adlrich 
RNAase free water GIBCO Invitrogen 
SM1 supplement  Stem Cell Technologies  
SDS Ficher-Scientific 
Sodium orthovanadate Sigma-Aldrich 
SsoFast
TM 
Eva
 
Green SuperMix Bio-Rad 
Sucrose VWR Chemicals Prolabo 
TripleXtractor, reagent for 
RNA isolation 
Grisp 
Tris Millipore 
Triton X‐100 Sigma-Aldrich 
Trypsin GIBCO Invitrogen 
Tween Fisher-Scientific 
β-mercaptoethanol Sigma-Aldrich 
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2.1. HIPPOCAMPAL CULTURES 
Primary cultures of hippocampal neurons were prepared from the hippocampi of E18-E19 
Wistar rat embryos. After dissection, hippocampi were treated with trypsin (0.06%, 15 min, 
37°C) in Ca
2+ 
- and Mg
2+
 - free Hank’s balanced salt solution (HBSS; 5.36 mM KCl, 0.44 
mM KH2PO4, 137 mM NaCl, 4.16 mM NaHCO3, 0.34 mM Na2HPO4.2H2O, 5 mM glucose, 
1 mM sodium pyruvate, 10 mM HEPES and 0.001% phenol red). The hippocampi were 
then washed with HBSS containing 10% fetal bovine serum, to stop trypsin activity and 
transferred to Neurobasal medium supplemented with SM1 supplement (1:50 dilution), 25 
µM glutamate, 0.5 mM glutamine and 50 µg/ml gentamycin. The cells were dissociated in 
this solution, and the homogenate was filtered (filter of 0.22 µm) to selected only the well 
dissociated cells. The cells were counted and plated on 6 well plates at the density of 
90.0x10
3
cell/cm
2
, previously coated with poly-D-lysine (0.1 mg/mL) or on poly-D-lysine 
coated glass coverslips at the density of 80x10
3
 cell/cm
2
. The cells were maintained in a 
humidified incubator with an atmosphere of 95% air and 5% CO2, at 37°C for 15 days. At 
day 2 in vitro the cell division inhibitor 5-Fluoro-2′-deoxyuridine (FDU, 10µM, Sigma-
Aldrich) was added to the cultures in order to prevent the proliferation of non-neuronal 
cells. After 7 days in vitro, one third of the culture medium was replaced with fresh 
medium without glutamate. 
 
2.2. CORTICAL NEURON CULTURES 
Primary cultures of cortical neurons were prepared from the brain cortex of E18-E19 
Wistar rat embryos. After dissection, the cortices were washed with HBSS and were then 
treated with trypsin (0.25%, 15 min, 37°C). The trypsinized tissue was washed 6 times and 
the cells were dissociated in planting medium (MEM supplemented with 10% horse serum, 
0.6% glucose and 1 mM pyruvic acid). The resulting suspension was filtered (filter of 0.22 
µm) to isolate the well dissociated cells. The cells were plated at a density of 100x10
3
 
cells/cm
2
. After 2 hours the plating medium was replaced with Neurobasal medium 
supplemented with SM1 supplement (1:50 dilution), 0.5 mM glutamine and 50 µg/ml 
gentamycin. The cells were maintained in a humidified incubator with an atmosphere of 
95% air and 5% CO2,  at 37°C for 15 days. At day 2 in vitro the cell division inhibitor FDU 
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(10 µM) was added to the culture medium. One third of the culture medium was replaced 
with fresh medium twice a week. 
 
2.3. GLIAL CELL CULTURES 
Cultures of glial cells were prepared from the brain cortex of E18 Wistar rat embryos. After 
dissection, the brain cortices were washed with HBSS and mechanically dissociated in 
DMEM (Dulbecco’s Modified Eagle Medium) supplemented with 20% of fetal bovine 
serum (FBS) and 1% PenStrep. The cells were dissociated in this solution, and the resulting 
suspension was filtered with a filter of 0.22 µm to better separate the cells. Finally, the 
dissociated cells were plated in the same medium. The cells were kept in a humidified 
incubator at 37°C with an atmosphere of 95% air and 5% CO2. The day after the culture 
medium was completely replaced with fresh medium, and additional changes of the 
medium were performed twice per week, with decreasing amount of FBS (20%, 15%, 10%) 
until the cells became confluent.  
 
2.4. ASTROCYTE CULTURES 
Astrocyte cultures were prepared from the brain cortex of E20 Wistar rat embryos. After 
dissection, the brain cortices were washed with HBSS and carefully homogenised. The 
resulting suspension was filtered with a filter of 0.22 µm to better separate the cells. The 
dissociated cells were then plated in the in 75 cm
2
 flasks with glia medium (MEM 
supplemented with 10% of FBS, 6% glucose, 1% PenStrep) at the concentration of ~2-
3x10
6
 cells/flask. The cells were kept in a humidified incubator at 37°C with an atmosphere 
of 95% air and 5% CO2. The day after the culture medium was completely replaced with 
fresh medium to remove dead cells. Twice a week, the flasks were vigorously shake and the 
medium was changed (this step allow the detachment of contaminating cells contributing 
for the purity of astrocyte cultures). Once confluent the astrocytes are ready to be used. 
 
2.5. OXYGEN-GLUCOSE DEPRIVATION (OGD) OF HIPPOCAMPAL, 
CORTICAL NEURONS AND GLIAL CELLS  
Hippocampal and cerebrocortical neurons (15 DIV) were incubated in a glucose-free saline 
medium (25 mM sucrose, 1.8 mM CaCl2, 25 mM NaHCO3, 10 mM HEPES, 116 mM NaCl, 
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5.4 mM KCl, 0.8 mM MgSO4, 1 mM NaH2PO4, 0.0005% Phenol red), while glial cells 
were incubated in a glucose and sucrose-free saline medium (1.8 mM CaCl2, 25 mM 
NaHCO3, 10 mM HEPES, 116 mM NaCl, 5.4 mM KCl, 0.8 mM MgSO4, 1 mM NaH2PO4, 
0.0005% Phenol red) in an anaerobic chamber with 10% H2, 85% N2, 5% CO2 (Forma 
anaerobic System, Thermo Fisher Scientific), at 37°C for 1.5 h. The OGD medium was 
then replaced by conditioned medium or fresh medium in the case of glial cells, and the 
cultures were returned to the humidified 95% air/5% CO2 incubator for the indicated 
periods of time (indicated as post-incubation period in the results section) (Chapter 3). 
Under control conditions (Sham) the cells were incubated in the saline buffer (25 mM 
glucose, 1.8 mM CaCl2, 25 mM NaHCO3, 10 mM HEPES, 116 mM NaCl, 5.4 mM KCl, 
0.8 mM MgSO4, 1 mM NaH2PO4, 0.0005% Phenol red) and kept in the humidified 95% 
air/5% CO2 incubator at 37°C.  
When appropriate neurons were incubated with phosphatase inhibitors: Cyclosporin A 1µM 
(inhibitor of calcineurin) and Okadaic acid 1 µM (inhibitor of serine/threonine protein 
phosphatases PP2A-C), with the calpain inhibitor MDL28170 (50 µM) and with the 
phosphorylation activators: Forskolin (FSK, 1 µM) and Phorbol-12-Myristate-13-Acetate 
(PMA, 20 nM). Transcription inhibition was performed by incubation with Actynomicin D 
(1 µM). When tested, the calpain inhibitor and Actynomicin D were added 30 min before 
OGD and were also present during and after the insult. 
To perform the experiments with calpastatin overexpression (endogenous calpain inhibitor), 
hippocampal neurons (10 DIV) were infected with adenoassociated virus serotype 1 (AAV 
type 1) expressing calpastatin or GFP. Five days after infection neurons were subjected to 
OGD. 
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2.6. MIDDLE CEREBRAL ARTERY OCCLUSION  
Focal cerebral ischemia was induced by the transient occlusion of the right middle cerebral 
artery (MCA), using the intraluminal filament placement technique as described previously 
(Nygren and Wieloch, 2005). Briefly, adult male mice were anesthetized by inhalation of 
2.5% isoflurane (IsobaVet, Schering-Plough Animal Health) in O2:N2O (30:70). Anesthesia 
was subsequently reduced to 1.5–1.8% isoflurane and sustained throughout the occlusion 
period. Body temperature was kept at ~37°C throughout the surgery period. To monitor 
regional cerebral blood flow (rCBF), an optical fiber probe (Probe 318-I, Perimed) was 
fixed to the skull at 2 mm posterior and 4 mm lateral to bregma and connected to a laser 
Doppler flow meter (Periflux System 5000, Perimed). A filament composed of 6 – 0 
polydioxanone suture (PSD II, Ethicon) with a silicone tip (diameter of 225–275 µm) was 
inserted into the external carotid artery and advanced into the common carotid artery. The 
filament was retracted, moved into the internal carotid artery, and advanced until the origin 
of the MCA, given by the sudden drop in rCBF (~70% of baseline). After 45 min, the 
filament was withdrawn and reperfusion observed. The animals were placed in a heating 
box at 37°C for the first 2 h after surgery and thereafter transferred into a heating box at 
35°C, to avoid postsurgical hypothermia. Thirty minutes and 24 h after the onset of 
reperfusion, 0.5 ml of 5% glucose were administered subcutaneously. Temperature and 
sensorimotor deficits were assessed at 1, 2 h and 24 h after the surgery. Body weight was 
controlled daily. In sham surgeries, the filament was advanced up to the internal carotid 
artery, and withdrawn before reaching the MCA. The Ethics Committee for Animal 
Research at Lund University approved animal housing conditions, handling, and surgical 
procedures. Eleven to 36 weeks old C57BL/6J male mice (weight: 23.0 g to 37.9 g; Lund 
University breeding facility) were housed under diurnal conditions with ad libitum access 
to water and food before and after surgery. Mice were anesthetized 48 h after MCA 
occlusion (MCAO) or sham surgery, by inhalation of 2.5 % isoflurane and were then 
perfused transcardially with 0.9 % NaCl for 2 min before decapitation. Upon removal of 
meninges, brains were rapidly isolated and frozen by immersion in isopentane at -40°C, 
further cooled down to -70°C and stored at -80°C. The infarct core and remaining 
ipsilateral tissue (designated as penumbra for simplification) were dissected, as well as the 
contralateral cortex, from coronal brain sections covering the majority of damage. More 
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specifically, consecutive 2 mm, 1 mm and 2 mm thick brain sections were made, starting at 
2 mm from the olfactory bulb. Dissections were performed at -15°C, a temperature that 
allows an easy detachment of the infarct core and penumbra. The cortical-striatal infarcts 
obtained were illustrated in (Inacio et al., 2011). Equivalent brain regions were dissected 
from sham-operated mice, which were also designated as infarct core and penumbra, and 
from the contralateral cortex. For each animal, corresponding regions from each of 3 
consecutive brain sections were pulled together. Samples were then homogenized and 
processed for Western blotting as previously described (Inacio et al., 2011). Cellular 
protein extraction was performed by mechanical homogenization of the tissue and 
incubation in lysis buffer: 20 mM Tris (pH 7.5), 150 mM NaCl, 1 mM EDTA, 1 mM 
EGTA, 1% Triton-X100, 2.5 mM sodium pyrophosphate, 1 mM β-glycerolphosphate, 1 
mM orthovanadate and 1 mM PMSF, supplemented with a protease inhibitor cocktail 
(P8340, Sigma-Aldrich). Following 30 min incubation at 4°C, samples were centrifuged at 
18000x g, for 15 min. Total protein concentration in lysates was determined by the 
Bradford assay, using serum bovine albumin (Sigma) as standard. 
 
2.7. WESTERN BLOTTING 
Total cell extracts were prepared at different time period of post-incubation after OGD as 
indicated in the results section. After washing the cells twice with ice-cold PBS buffer (13.7 
mM NaCl, 2.7 mM KCl, 1.8 mM K2HPO4, 10 mM NaH2PO4.2H20), the cells were lysed 
with RIPA buffer (150 mM NaCl, 50 mM Tris.HCl, 5 mM EGTA, 1% Triton X-100, 0.5% 
Deoxycholic acid, 0.1% Sodium dodecyl sulphate) supplemented with 1 mM DTT and a 
cocktail of protease inhibitors (0.1 mM PMSF, 1 μg/ml chymostatin, 1 μg/ml leupeptin, 1 
μg/ml antipain, 1 μg/ml pepstatin; Sigma‐Aldrich Química). For phosphorylation studies 
the RIPA lysis buffer was also supplemented with 50 mM NaF and 1.5 mM sodium 
orthovanadate. The extracts were frozen (at -80°C), defrost and centrifuged at 16.000xg for 
10 min. In the case of glial cells, before centrifugation, the extracts were sonicated for 5 
min with ultrasonic sonicator bath at 4°C. The protein present in the supernatants was then 
quantified using the BCA method (Thermo Scientific). The samples were diluted with a 5x 
concentrated sample buffer (200 mM Tris.HCl, 8% glycerol, 1.6% SDS, 0.001% 
bromophenol blue and 5% β-mercaptoethanol). Protein samples were separated by SDS‐
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PAGE, in 10% polyacrylamide gels, and transferred to PVDF membranes. Membranes 
were blocked in 5% milk in TBS-T (20 nM Tris, 13.7 mM NaCl, 0.1% Tween, pH 7.6) and 
were then incubated with primary antibodies diluted in 0.5% milk TBS-T (overnight at 
4°C). Finally, the membranes were washed and exposed to alkaline phosphatase‐conjugated 
secondary antibodies (1:20.000 dilution; 1 h at room temperature, GE Healthcare or 
Jackson ImmunoResearch). Alkaline phosphatase activity was visualized using ECF on the 
Storm 860 Gel and Blot Imaging System (GE Healthcare). The following primary 
antibodies were used: anti‐HAP1 (1:750, Santa Cruz Biotechnology); anti-Synaptophysin 
(1:20000, Abcam), anti-β-tubulin (1:300000, Sigma-Aldrich), anti-GFP Rabbit (1:1000, 
MBL), anti-calpastatin  (1:200, Santa Cruz Biotechnology). 
 
2.8. IMMUNOCYTOCHEMISTRY 
Hippocampal neurons (15 DIV) were fixed with 4% paraformaldehyde/sucrose in PBS and 
permeabilized with 0.3% Triton X‐100 in PBS for 5 min. The cells were then incubated in 
PBS/BSA 10% for 60 min at RT, and further incubated with the primary antibodies diluted 
in PBS/BSA 3%, overnight at 4°C. Hippocampal neurons were washed 6 times with PBS 
and were incubated with the appropriate secondary antibodies, for 1 h at RT. The coverslips 
were mounted with a fluorescence mounting medium (DAKO, Denmark). Imaging was 
performed in an Axio Observer 2.1 fluorescence microscope, coupled to an Axiocam HRm 
digital camera, using a 63x oil objective. The primary antibodies used were anti-HAP1 
(1:250, Santa Cruz Biotechnology), anti-GFAP (1:1000, NeuroMab) and anti-MAP2 
(1:10000, Abcam). The secondary antibodies used were: anti-Chicken IgG conjugated with 
AMCA Fluor 350 (1:200, Invitrogen), anti-mouse IgG conjugated with Alexa Flour 488 
(1:500, Invitrogen) or with Alexa Flour 568 (1:500, Invitrogen).  
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2.9. q-PCR ANALYSES  
2.9.1. TOTAL RNA EXTRACTION, RNA QUALITY AND RNA CONCENTRATION  
RNA extraction from cultured glial cells was performed with TripleXtractor (Grisp). 
Briefly, 1 mL of TripleXtractor was added to each well of 6-well cluster plate. The extracts 
were diluted with chloroform and the samples were centrifuged for 15 minutes at 4°C to 
separate the different phases: inferior red phase containing soluble proteins and DNA, 
intermediate chloroform phase containing denatured proteins and top colorless phase 
containing total RNA. The top phase was removed and the RNA was precipitated with 
isopropanol followed by centrifugation. The resulting pellet containing RNA was washed 
with 75% ethanol, centrifuged and air-dried. RNA was resuspended with 20 µl of RNAase 
free water (GIBCO Invitrogen). RNA quality and integrity was evaluated using Experion 
electrophoresis for automated running RNA (Bio-Rad). RNA concentration was determined 
using NanoDrop 2000c/2000 UV –Vis spectrophotomer (Thermo scientific). The samples 
were kept at - 80°C. 
 
2.9.2. REVERSE TRANSCRIPTION REACTION  
First strand cDNA was synthesized from 1 µg of total RNA using iScript cDNA synthesis 
kit (Bio-Rad) following the manufacturer’s specifications. The thermocycler protocol 
includes four steps: 1) 5 min at 25°C; 2) 30 min at 42°C; 3) 5 min at 85°C; 4) Hold at 4°C. 
 
2.9.3. PRIMER DESIGN  
The primers for real-time PCR were designed using “Beacon Designer 7” software (Primer 
Biosoft Internationl), with the following specification: 1) GC content about 50%; 2) 
Anneling temperature (Ta) between 55 ± 5°C; 3) Secondary structures and primer-dimers 
were avoided; 4) Primer length 18-24 bp; 5) Final product length between 100-200 bp. The 
Primers were designed using a sequence common to the two HAP1 isoforms (HAP1-A and 
HAP1-B). The HAP1 Forward primer sequence was: CAGGAAGAAGATCACCGAAGA; 
the reverse primer sequence was: GTGTTCAGGTCCCGTTCT (Sigma).  
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2.9.4. REAL-TIME PCR 
Real-time PCR experiments were performed as previously described (Mele et al. 2014). 
Gene expression analysis was performed using SsoFast
TM 
Eva
 
Green SuperMix (BioRad). 
Briefly, 2 µl cDNA samples were diluted 1:10 and added to 10 µl of EvaGreen 2x and to 
the specific primers at the final concentration of 250 µM in a total volume of 20 µl. The 
thermocycling reaction was composed of the following steps: 1) activation of the Sso7d 
fusion DNA polymerase (95°C for 30 s), 2) denaturation (45 cycles of a 10 s step at 95°C), 
3) annealing (30 s at the optimal annealing temperature for each set of primers), 4) 
elongation (30 s at 72°C). At the end of thermocycling reaction a melting step was 
performed (starting at 55°C with a rate of 0.5°C per 10 s, up to 95°C). The fluorescence 
was measured after the extension step, using the iQ5 Multicolor Real‐Time PCR Detection 
System (BioRad). To calculate the efficiency of each set of primers the assays included a 
nontemplate control and a standard curve of cDNA using serial dilutions (1:10, 1:100, 
1:1000). All reactions were run in duplicate. The value used for the quantification was the 
threshold cycle (Ct; the detectable fluorescence signal above background resulting from the 
accumulation of amplified product), a value that is a proportional measure of the starting 
concentration of the target sequence. The threshold base line was always set at the 
beginning of the exponential phase. Data analysis was performed using the GenEx (MultiD 
Analyses) software for Real‐Time PCR expression profiling. 
 
2.10. PLASMIDIC DNA AMPLIFICATION AND PURIFICATION 
2.10.1. BACTERIA TRANSFORMATION  
The following transformation protocol was used to obtain DNA from kanamycin resistant 
pEGFP-HAP1A and pEGFP-HAP1B vectors: 1µl of vector was added to competent E.Coli 
cells (DH5α) prepared with the Calcium Chloride protocol. After 30 min incubation on ice, 
the cells were submitted to an heat shock at 42°C for 45 s, followed by 5 min on ice. The 
cells were then pleated on Petri dishes containing LB-Agar and 50 µM kanamycin, and 
were then incubated overnight at 37°C.  
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FIGURE 2.1. Map of the kanamycin resistant pEGFP (4724 bp) vector.  
 
 
 
 
FIGURE 2.2. Schematic representation of the EGFP-HAP1-A and EGFP-HAP1-B fusion 
proteins.  
These sequences were cloned in the kanamycin resistant pEGFP vector (4724 bp).  
 
2.10.2. BACTERIA GROWTH 
One single colony selected by kanamycin resistance after bacteria transformation was 
picked and incubated ON in LB medium supplemented with 50 µM kanamycin. After 
bacteria growth the DNA extraction was performed with HiPure Plasmid Filter Maxiprep 
Kit (Invitrogen) and NzyMiniprep (Nzytech). The concentration of DNA was determined 
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using NanoDrop 2000c/2000 UV–Vis spectrophotomer (Thermo scientific). The samples 
were kept at -20°C. 
 
2.11. TRANSFECTION OF PRIMARY NEURONAL CULTURES  
Hippocampal neurons were transfected with pEGFP, myc-huGABAAR β3 (Mele et al. 
2014), pEGFP-HAP1-A and pEGFP-HAP1-B (Gift from Ghislaine Poizat, Frédéric 
Saudou’s laboratory, Institute Curie, Orsay, France), using the calcium phosphate co-
precipitation method. 2 µg of DNA for each cover slip were used, diluted in Tris-EDTA 
(TE) pH 7.3 and mixed with 2.5 M of CaCl2. The DNA/TE/CaCl2 mix was added to 2x 
HEPES buffered saline solution pH 7.2 (250 mM NaCl, 10 mM KCl, 1.4 mM Na2HPO4, 11 
mM dextrose, 42 mM HEPES). The precipitates were allowed to develop at a room 
temperature for 30 min, protected from light, vortexing every 5 min. Neurons were 
prepared to receive the precipitates by adding 2 mM kynurenic acid (Sigma) in cultured-
conditioned medium for 20 min. The precipitates were added to the cells drop-wise in the 
center of the coverslip and incubated for 2 h at 37°C, in an incubator with 95% air/5% CO2.  
The cells were then washed with glutamate-free Neurobasal medium supplemented with 10 
mM kynurenic acid and incubated for 20 min in an incubator with 95% air/5% CO2. Finally, 
the medium was replaced with the initial culture-conditioned medium, and the cells were 
incubated in a 95% air/5% CO2 incubator for 48 h at 37°C to allow protein expression. Cell 
cultures were then subjected to OGD for 90 min and different times of reoxygenation (0 h 
and 1 h). After the insult the cells were subjected to immunocytochemistry, using a 
fluorescence assay for receptor internalization and recycling.  
 
2.12. IMMUNOCITOCHEMISTRY FOR MEMBRANE ASSOCIATED 
PROTEINS  
A live staining protocol was used to study the effect of OGD on the levels of GABAAR β3 
subunit on the plasma membrane, in the absence of HAP1-A or HAP1-B. Cultured living 
hippocampal neurons (15 DIV), transfected with huGABAAR β3, EGFP-HAP1 A or EGFP-
HAP1 B, and subjected or not to OGD (90 min), were incubated with the primary antibody 
anti-myc GABAAR β3 (1:300 in culture-conditioned medium; Cell Signaling) at RT for 10 
min. The cells were washed with pre-warmed PBS and were then fixed with 4% 
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paraformaldehyde/sucrose in PBS and incubated with the secondary antibody (Alexa Flour 
568 goat anti-mouse, 1:300 Invitrogen) for 1 h at RT. The preparations were washed six 
times with PBS and the cells were permeabilized with 0.3% Triton X‐100 in PBS and 
blocked with 10% BSA in PBS for 60 min at RT. Then the cells were incubated ON at 4°C 
with an rabbit anti-GFP antibody (1:500, MBL), diluted in PBS/3% BSA. The cells were 
washed 6 times with PBS and incubated with the secondary antibody (Alexa Flour 488 goat 
anti-rabbit, 1:500 Invitrogen) for 1 h at RT. The coverslips were mounted in a florescence 
mounting medium and imaging was performed with Axio Observer 2.1 fluorescence 
microscope . 
 
2.13. FLUORESCENCE ASSAY OF RECEPTOR INTERNALIZATION  
The protocol used for fluorescence assay of receptor was previously described (Mele et al. 
2014). After the OGD insult, cultured hippocampal neurons transfected with huGABAAR 
β3, EGFP-HAP1 A or EGFP-HAP1 B, were incubated at RT for 10 min in the presence of 
a high concentration of the primary antibody (mouse) anti-myc (1:300, Cell Signaling) 
diluted in conditioned medium to label the receptors on the cell surface. The cells were then 
washed with PBS at 37°C to remove the unbound antibody and were again incubated in 
conditioned medium for 20 min at 37°C to allow receptor internalization. After this 
incubation the cells were fixed for 15 in 4% paraformaldehyde/sucrose and washed twice 
with PBS. Next, neurons were incubated with a super-saturating concentration (1:300) of 
the first secondary antibody (goat Alexa Flour 568 anti-mouse; Invitrogen) for 1 h at RT 
and washed 4 times with PBS. Then the cells were permeabilized (0.3% Triton X-100 for 5 
min at 4°C) and washed for 5 min at RT before incubation with 10% BSA in PBS for 60 
min at RT. To label the receptors that were internalized, the cells were incubated with the 
second secondary antibody (goat Alexa Flour Far-red 647 anti-mouse; 1:500 Invitrogen) for 
1 h at RT. This strategy allows distinguishing the surface receptors from those receptors 
that have been internalized before fixation (Goodkin et al. 2005). To identify the cells that 
were transfected with EGFP-HAP1 A or EGFP-HAP1 plasmids, the cells were then 
incubated with the primary antibody (rabbit) anti-GFP (1:500, Invitrogen) overnight at 4°C, 
washed 4 times with PBS and incubated with the secondary antibody (Alexa Flour goat 488 
anti-rabbit; 1:500 Invitrogen). Finally, the cells were washed 4 times with PBS and the 
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cover slips were mounted on slides with fluorescence mounting medium (DAKO). The 
coverslips were mounted in a florescence mounting medium and imaging was performed 
with Axio Observer 2.1 fluorescence microscope. 
 
 
 
FIGURE 2.3. Schematic representation of the fluorescence assay used to assess receptor 
internalization. 
 
2.14. RECEPTOR RECYCLING ASSAY  
Cultured living hippocampal neurons (15 DIV), transfected with myc-huGABAAR β3, 
EGFP-HAP1 A or EGFP-HAP1 B, were incubated at RT for 10 min in the presence of a 
high concentration of first primary antibody, mouse anti-myc (1:300, Cell Signaling) 
diluted in conditioned medium. The cells were then washed with PBS pre-warmed at 37°C 
to remove the unbound antibodies and further incubated with conditioned medium at 37°C 
for 20 min to allow the internalization of antibody-bound receptors. The antibodies 
remaining on the cell surface were then removed by incubation with a stripping solution 
(0.5 M NaCl and 0.2 M acetic acid) on ice for 4 min (Passafaro et al. 2001). Neurons were 
then washed extensively with ice-cold PBS and returned back to culture medium at 37°C 
for 20 min to allow the receptor recycling. After recycling, neurons were fixed and myc-
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antibody complexes recycling back to the surface were detected by incubation of the cells 
with the first secondary antibody (Alexa Flour goat 568 anti-mouse; 1:200 Invitrogen). To 
allow the detection of the receptors that were not recycled, the cells were then 
permeabilized and incubated with 10% BSA in PBS for 1 h at RT. After this blocking step, 
the cells were incubated with the secondary antibody for 1 h at RT (goat Alexa Flour 670 
anti-mouse; 1:200 Invitrogen). To detect the cells that were transfected with EGFP-HAP1 
A or EGFP-HAP1 plasmids, cells were incubated with the primary antibody (rabbit) anti-
GFP (1:500) overnight at 4°C. Neurons were the incubated with the secondary antibody 
(Alexa Flour 488 anti-rabbit 1:400 Invitrogen) for 1h at RT. Finally, the coverslips were 
mounted on slides with fluorescence mounting medium (DAKO) and imaging was 
performed with Axio Observer 2.1 fluorescence microscope . 
 
 
FIGURE 2.4. Schematic representation of the receptor recycling assay. 
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3.1. CHARACTERIZATION OF CULTURED HIPPOCAMPAL NEURONS 
The protocol to culture hippocampal neurons was well established and already used in our 
laboratory. To reduce the contamination with astrocytes we supplemented the culture 
medium with 5-fluoro-2’-deoxyuridine (FDU, 10 µM), which inhibits thymidy-late 
synthase (TS) causing an imbalance of the intracellular deoxyribonucleoside triphosphate 
(dNTP) pool with consequent inhibition of DNA synthesis (Yoshioka et al. 1987). This 
inhibitor was added to the cultured hippocampal neurons after two days in culture. After 
fifteen days in culture the cells were fixed and immunocytochemistry was performed to 
label the glial fibrillary acidic protein (GFAP) and the microtubule-associated protein 2 
(MAP2) that is a somato-dendritic marker. The cells were then counted and the percentage 
of glial cells was calculated. The average percentage of glial cells in the cultures was 4.2% 
(n=3) (Figure 3.1). 
 
 
 
Figure 3.1. Characterization of cultured hippocampal neurons at DIV15.  
The culture medium was supplemented with 5-fluoro-2’-deoxyuridine (FDU, 10 µM) at DIV2 to 
inhibit glial cell growth. At DIV15 the cells were fixed and the neurons were labelled with anti-
MAP2 while glial cells were labelled with an anti-GFAP antibody. The glial cells were counted and 
their abundance was calculated as a percentage of the total number of cells (neurons + glial cells). 
The experiment was performed three times in independent preparations. 
 
3.2. OGD DECREASES HAP1 TOTAL PROTEIN LEVELS BY A 
CALPAIN DEPENDENT MECHANISM 
The sorting of GABAAR after internalization is determined by its interaction with the 
HAP1 protein (Kittler et al. 2004). To assess the effect of OGD, a well-established in vitro 
model of global cerebral ischemia (Dawson et al. 1996; Goldberg and Choi 1993), on 
HAP1 total protein levels, we subjected hippocampal neurons to 90 min of OGD and the 
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cells were further incubated in culture-conditioned medium for different time periods. 
HAP1 total protein levels were analyzed with western blot using a specific antibody against 
amino acids common to the two isoforms of HAP1, HAP1-A and HAP1-B. The results 
show no significant differences in HAP1 total protein levels immediately after OGD, but at 
a decrease of ~20% was observed 2 h after the stimulus, and of 40% at 4 h and 6 h after 
injury. HAP1 protein levels were further decreased to ~50% 8 h after OGD (Figure 3.2 A).  
The absence of oxygen and glucose during OGD induces ATP depletion and the dissipation 
of cellular ionic gradients. These mechanisms lead to an increase in the intracellular 
calcium concentration with a consequent activation of calpains (Saido et al. 1994; 
Vanderklish and Bahr 2000), a family of calcium-dependent enzymes which cleave 
cytoskeleton proteins and other substrates (Bevers and Neumar 2008). To understand 
whether calpains are involved in the OGD-induced downregulation of HAP1 protein, 
hippocampal neurons were subjected to OGD (90 min) in the presence or absence of the 
chemical calpain inhibitors MDL28170 (50 µM). The results show that MDL28170 
abrogates the effect of OGD on HAP1 total protein when evaluated 8 h after the insult, 
preventing its reduction in hippocampal neurons subjected to OGD (Figure 3.2 B).  
 
 
 
Figure 3.2. HAP1 total protein levels are downregulated in vitro ischemia (OGD) by a calpain-
dependent mechanism. 
(A) Cultured hippocampal neurons (15 DIV) were exposed to OGD (90 min) and were further 
incubated in culture-conditioned medium for the indicated periods of time: 0 h, 2 h, 4 h, 6 h and 8 h 
(post-incubation). (B) Cultured hippocampal neurons (15 DIV) were exposed to OGD for 90 min in 
the presence or absence of MDL28170 (50 µM) and were further incubated in culture-conditioned 
medium for 8 h (post-incubation) with the same inhibitors. (A-B) HAP1 total protein levels were 
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analyzed with western blot and the results were normalized with the loading control synaptophysin. 
Results are the men ± SEM of at least 3 independent experiments performed in distinct preparations. 
One-way ANOVA was performed as statistical analysis, followed by Dunnett’s and/or Bonferroni 
test. **p<0.01, ***p<0.001, 
##
p<0.01- significantly difference when compared to control conditions 
or for the indicated comparisons. Non-significant differences were indicate as ns. 
 
To further investigate whether calpains act directly on the cleavage of HAP1, we used 
different algorithms that predict potential proteolytic cleavage sites. Polypeptide sequences 
enriched in proline (P), glutamic acid (E), serine (S) and threonine (T) called PEST 
sequences are targeted by proteases for rapid destruction (Rogers et al. 1986). This process 
may be mediated by calpain proteins (Shumway et al. 1999). The Software EMBOSS 
(http://sourceforge.net) was used to identify the sites with the highest PEST sequence score 
in the two rat HAP1 isoforms (HAP1-A and HAP1-B). Figures 3.3 A and B show the 
presence of putative PEST sequences in both HAP1 isoforms: from amino acid 476 to 532 
(score +19.36) and from amino acid 4 to 42 (score +14.8). Using the GPS-CCD program 
(Calpain Cleavage Detector based on the algorithm for Group-based prediction System, 
available at http://ccd.biocuckoo.org/), the sites that were retrieved with the highest score 
were the following: HAP1-A - Gln342 (1.332), Ala367 (1.34), Arg403 (1.079), Ser404 
(1.008); HAP1-B - Gln342 (1.332), Ala367 (1.34), Arg403 (1.079), Ser404 (1.008), 
Asp579 (1.125). 
It was proposed that calpains cleave their substrates in disordered segments of the proteins 
(Tompa et al. 2004). We used the metaPrDOS bioinformatic tool (http://prdos.hgc.jp/cgi-
bin/meta/top.cgi) to predict the disorder tendency in the two isoforms of HAP1 protein. The 
results showed that both HAP1 isoforms presents a considerable degree of disorder in 
different segments (amino acids in HAP1-A: 1 to 71, 88 to 101, 216 to 257, 361 to 378, 390 
to 424, 456 to 520, 564 to 599; amino acids in HAP1-B: 1 to 71, 88 to 101, 106 to 119, 216 
to 258, 365 to 378, 380 to 423, 456 to 520, 564 to 593, 601 to 629) (Figure 3.3 C and D). 
These bioinformatic analyses reinforce the hypothesis that HAP1 protein levels may be 
regulated by calpain activity.  
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Figure 3.3. Identification of putative sites of cleavage by calpains in HAP1 protein. 
Analysis of the putative sites of cleavage by calpains in the HAP1-A (A) and HAP1-B (B), using 
the software EMBOSS. Positive values above the threshold +5.00 correspond to predicted cleavage 
sites. Prediction of the disorder tendency in HAP1-A (C) and HAP1-B (D) based on the analysis of 
amino acids sequences with meta PrDOS bioinformatic tool. Each peak labeled with a red line 
corresponds to disordered segment. The arrows indicate the cleavage sites.  
 
To confirm the results pointing to a role of calpains in the cleavage of HAP1 in 
hippocampal neurons exposed to OGD, we also evaluated the effect of calpastatin 
(endogenous inhibitor of calpains) on the total protein levels of HAP1 after OGD. 
Calpastatin is a natural specific inhibitor of calpains (Ishida et al. 1991; Lee et al. 1992) 
which binds to calpain forming a calpain-calpastatin complex (Tompa et al. 2002). Cultured 
hippocampal neurons (10 DIV) were infected with AAV type 1 virus that express 
calpastatin or GFP, and five days after infection hippocampal neurons were subjected to 
OGD (90 min) or incubated in sham conditions. Total HAP1 protein levels were analyzed 8 
h after the insult by western blot analysis. The results show a significant decrease of HAP1 
total protein levels in non-infected neurons (~40%) after OGD, and a slight but not 
significant reduction in cell death was observed when the cells overexpressing calpastatin 
(Figure 3.4). As expected, this protective effect was not observed in the cells transduced 
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with GFP. These results suggest that an upregulation of calpastatin protein levels reduce the 
OGD-induced downregulation of HAP1, but additional experiments are required to confirm 
the role of calpain in the cleavage of HAP1 using this experimental approach. 
 
 
 
Figure 3.4. Calpastatin prevents the OGD-induced reduction of HAP1 total protein.  
Culture of hippocampal neurons infected or not with AAV type 1 virus expressing calpastatin or 
GFP were exposed to OGD (90 min) and western blot analyses was performed 8 h (post-incubation) 
after the insult. HAP1 total protein levels were determined and successful infection was confirmed 
using specific antibodies against calpastatin and GFP. The results of HAP1 protein were normalized 
with the loading control synaptophysin. Results are the mean ± SEM of 3 independent experiments 
performed in distinct preparations. Statistical analysis was performed by one-way ANOVA, 
followed by Dunnett’s and Bonferroni test. **p<0.01, ***p<0.001, #p<0.05, ##p<0.01 - significantly 
difference when compared to control conditions or for the indicated comparisons. Non-significant 
differences are indicated as ns. 
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3.3. INHIBION OF PP1/PP2A PHOSPHATASES PREVENTS OGD-
INDUCED REDUCTION OF HAP1 PROTEIN LEVELS 
It has been found that HAP1 interaction with several different motor proteins is required for 
intracellular transport (Rong et al. 2007; Engelender et al. 1997) and these interactions were 
shown to be affected by protein phosphorylation (Rong et al. 2006). Here we evaluated 
whether HAP1 protein expression is modulated by phosphorylation/dephosphorylation 
mechanisms in hippocampal neurons exposed to ischemic conditions. Cultured 
hippocampal neurons (15 DIV) were subjected to OGD for 90 min, and the cells were 
further incubated for 8 h in the presence of okadaic acid (0.5 µM) [protein serine/threonine 
phosphatase 1, 2A inhibitor (Garcia et al. 2003)], or with cyclosporin A (1µM) (calcineurin 
inhibitor). Incubation of hippocampal neurons with okadaic acid under control conditions 
upregulated HAP1 protein levels. This robust effect may contribute, at least in part, to the 
preservation of HAP1 protein levels, as compared with the control conditions, when 
hippocampal neurons were subjected to transient OGD (Figure 3.5 A). Although 
cyclosportin A had a small but significant effect on HAP1 protein levels under control 
conditions, the phosphatase inhibitor was without effect on the downregulation of HAP1 
observed after OGD (Figure 3.5 A). The effect of protein phosphorylation on OGD-induced 
cleavage of HAP1 was further investigated in experiments where hippocampal neurons 
were incubated with forskolin (FSK), an activator of adenylyl cyclase, or with Phorbol 12-
myristate 13-acetate (PMA), a specific activator of group A (α, βI, βII, γ) and group B (δ, ε, 
η, θ) Protein Kinase Cs (PKCs) (Figure 3.5 B). The results showed no effect of these two 
compounds on HAP1 protein expression upon OGD, suggesting that HAP1 downregulation 
induced by the ischemic insult is not affected by PKA and PKC.  
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Figure 3.5. HAP1 total protein levels are dowregulated in vitro ischemia (OGD) by a 
mechanism dependent on the activity PP1/PP2A phosphatases.  
(A) Cultured hippocampal neurons (15 DIV) were exposed to OGD for 90 min in the presence or in 
the absence of 0.5 µM okadaic acid or 1µM cyclosporin A. (B) Cultured hippocampal neurons (15 
DIV) were exposed to OGD for 90 min in the presence or in the absence of 1 µM FSK or 20nM 
PMA. (A-B) HAP1 total protein levels were determined by western blot analysis, 8 h after the insult, 
and the results were normalized with the loading control synaptophysin. Results are the mean ± 
SEM of at least 3 independent experiments performed in different preparations, and are expressed 
as percentage of the control. Statistical analysis was performed by one-way ANOVA, followed by 
Dunette’s or Bonferroni test. *p<0.05, **p<0.01, ***p<0.001, ##p<0.01  ###p<0.001 - significantly 
different when compared with control conditions or for the indicated comparisons. Non-significant 
differences were indicated as ns. 
 
3.4. HAP1 TOTAL PROTEIN LEVELS ARE INCREASED AFTER 
TRANSIENT MCAO, AN IN VIVO MODEL OF CEREBRAL ISCHEMIA 
To determine whether HAP1 is also downregulated in brain ischemia in vivo, we measured 
the changes in HAP1 total protein levels in the brain of adult mice subjected to MCAO, a 
model of focal cerebral ischemia. Different regions of the brain, the infarct core, the 
penumbra as well as the ipsilateral brain hemisphere, were analyzed 48 h after transient (45 
min) MCAO. Surprisingly, western blot analysis for HAP1 showed an increase of total 
protein levels of about 50%. No significant differences were observed in the penumbra and 
contralateral cerebrocortical regions (Figure 3.6). These results indicate that MCAO 
upregulates HAP1 protein in the ischemic core brain region. 
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Figure 3.6. HAP1 protein is upregulated in the ischemic core of transient brain ischemia in 
vivo. 
Adult male mice (C57BL/6) were subjected to transient occlusion of the right middle cerebral artery 
(MCA) for 45 min, followed by reperfusion for 48 h. The control (sham) was subjected to surgery 
for the same times. HAP1 total protein levels were analyzed in different brain regions by western 
blot: ischemic core (IC) and penumbra (affected by MCAO) and ipsilateral brain hemisfere. HAP1 
total protein levels were analyzed also for the control in equivalent brain regions. The results were 
normalized with the loading control synaptophysin. Results are the men ± SEM of 3 independent 
experiments, using samples from different animals. Student’s t-test was performed as statistical 
analysis. Significant differences (**p<0.01) were considered from the ischemic core (IC) and Sham 
cortex in operated animals. Non-significant (ns) differences were considered comparing the 
penumbra and controlateral regions to the correspondent region in sham operated animals.  
 
3.5. OGD DECREASES HAP1 TOTAL PROTEIN LEVELS IN CORTICAL 
NEURONS AND INCREASES ITS LEVELS IN GLIAL CELLS 
To understand the differential effect of ischemic injury on HAP1 total protein levels, in the 
in vivo and in vitro models of brain ischemia, we investigated the OGD-induced alterations 
in the abundance of the protein in cultured cortical neurons and in cultured glial cells. In 
fact, a major difference between the in vivo and in vitro models of ischemia used in the 
experiments described above is the cellular heterogeneity of the system: the brain tissue 
analyzed in the MCAO experiments contains neurons and glial cells while the hippocampal 
cultures used in OGD studies are highly enriched in neurons.  
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Cerebrocortical neurons (15 DIV) were subjected to OGD for 90 min and the cells were further 
incubated in culture-conditioned medium for 8 h. HAP1 total protein levels were analyzed with 
western blot and the results showed a decrease of HAP1 total protein by about ~25 % in agreement 
with the results obtained in hippocampal neurons exposed to OGD (Figure 3.7). These results 
indicate that OGD affects the HAP1 protein levels in cultured cortical neurons as well as in 
hippocampal neurons. Similar experiments were performed using cultured cerebrocortical glial cells, 
which were subjected to OGD (90 min) and then incubated in DMEM (Dulbecco’s Modified Eagle 
Medium) supplemented with 15% of fetal bovine serum (FBS) for different periods of post-
incubation (Figure 3.8. A). HAP1 total protein levels were evaluated with western blot analysis 
right after OGD or at 4 h, 8 h, 24 h and 48 h after the stimulus. The results show a time dependent 
and transient effect of OGD on HAP1 protein levels. An increased in HAP1 was observed starting 8 
h after OGD, and the effect was statistically significant at 12 h of post-incubation (~40%). At a later 
time point, 48 h after the insult, we observed a significant decrease in HAP1 (~60%). These results 
suggest that the differential effects of in vivo and in vitro ischemia on HAP1 protein levels may be 
due to the distinct response by neurons and glial cells. 
 
 
 
Figure 3.7. HAP1 protein is downregulated in cortical neurons exposed to OGD.  
Cultured cortical neurons (15 DIV) were exposed to OGD for 90 min and were further incubated in 
culture-conditioned medium for 8 h (post-incubation). Total HAP1 protein levels was analyzed by 
western blot and the results were normalized with the loading control synaptophysin. Results are the 
mean ± SEM of at least 3 independent experiments performed in distinct preparations, and are 
expressed as percentage of the control. Statistical analysis was performed by Student’s t-test. 
**p<0.01 - significantly different when compared to control condition.  
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This is the first work in which HAP1 is shown to be present in glial cells. Although 
previous studies suggested the absence of HAP1 in mature astrocytes (Xiang et al. 2014), 
the results of the western blot experiments shown in Figure 3.8 B indicate that the protein is 
also expressed in mature astrocytes. This result was also confirmed with RT-PCR analysis 
in mature astrocytes using specific primers of HAP1 (data not shown).  
 
 
 
Figure 3.8. HAP1 protein levels are altered in glial cells exposed to OGD.  
(A) Cultured of glial cells were exposed to OGD for 90 min and further incubated in DMEM 
supplemented with 15% of FBS for 0 h, 4 h, 8 h, 12 h, 24 h or 48 h (post-incubation). HAP1 total 
protein levels were analyzed with western blot and the results were normalized with the loading 
control tubulin. The results are the mean ± SEM of 3 independent experiments performed in distinct 
preparations, and are expressed as percentage of the control. Statistical analysis was performed by 
one-way ANOVA, followed by Bonferroni’s test. *p<0.05, **p<0.01 - significantly different when 
compared to the respective control condition. (B) Western blot analysis of cultured mature 
astrocytes showing the presence of HAP1 protein.  
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3.6. OGD-INDUCED HAP1 mRNA ALTERATION IN GLIAL CELLS 
The expression of proteins in the cells is regulated by transcription, translation, 
biosynthesis and degradation mechanisms. To determine whether the observed OGD-
induced upregulation of HAP1 protein levels in glial cells (Figure 3.8) was due to changes 
in transcription activity we measured the changes in HAP1-mRNA under the same 
conditions. The levels of HAP1 mRNA were analyzed through PCR analysis using the total 
RNA extracted from glial cells after 90 min of OGD followed by 12 h of post-incubation. 
The GenEx software was used to choose the reference genes. Two methods of statistical 
analysis were used to identify the most suitable reference genes: 1) geNorm that compares 
the variations in all expression ratios for every candidate gene and recommends to use the 
last pair as optimum reference genes (with lower variation); 2) Normifinder that calculates 
both the variation of every gene within the group (intragroup variation) and the variation of 
every gene between the groups (intergroup variation), recommending the optimum pair of 
reference genes (Santos and Duarte 2008). Using this statistical methods the actin and 
tubulin mRNAs were chosen as reference genes to normalize the expression of HAP1 
mRNA. The results (Figure 3.9) show a small but not significant decrease of mRNA 
expression following the in vitro ischemic insult, suggesting that the alteration of HAP1 
protein levels observed in the same condition is not related to the changes in mRNA. 
However, the alterations in mRNA are normally faster and precede the changes in protein 
expression. Therefore the downregulation in HAP1 mRNA observed 12 h after OGD may 
account for the reduction in HAP1 protein levels observed 48 h after OGD (Figure 3.8). 
Thus, additional studies should be performed to determine whether the expression of HAP1 
gene is increased at early time points after the OGD insult.  
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Figure 3.9. OGD-induced alteration of HAP1 mRNA levels in glial cells. 
Cultured glial cells were exposed to OGD for 90 min and the mRNA was extracted for qPCR 
analysis 12 h after the stimulus (post-incubation). Results were normalized with the reference genes 
(tubulin and actin) and the mean ± SEM of at least 3 different experiments performed in 
independent preparations was calculated. The results are expressed as percentage of control (Sham). 
The differences obtained were not statistically significant, as determined by Student’s t-test. 
 
3.7. OVEREXPRESSION OF HAP1 PROTEIN ABROGATES THE OGD-
INDUCED REDUCTION OF GABAAR β3 SUBUNIT RECYLING RATIO 
Privious results from our laboratory showed a decreased GABAAR β3 subunit recycling rate and a 
reduction of GABAAR/HAP1 interaction in hippocampal neurons exsposed to OGD. Considering 
the role of HAP1 in the trafficking of GABAAR (Kittler et al. 2004), we investigated the effect of 
HAP1 overexpession on GABAAR surface expression and recycling. Cultured hippocampal neurons 
(13 DIV) were transfected with myc-tagged huGABAAR β3, GFP-tagged HAP1-A or GFP-tagged 
HAP1-B, and GABAAR β3 surface expression and recycling ratio were analyzed 2 days after 
transfection, following 90 min of OGD. The surface receptors were detected by 
immunocytochemistry under non-permeabilizing conditions, with an antibody against the 
extracellular myc-tag. The rate of receptor recycling was determined after labeling of the surface 
receptors immediately after OGD, and an additional incubation of 30 min after the stimulus was 
performed to allow the receptor recycling (this incubation period allows the detection of the OGD-
induced decrease in the recycling). Immunocytochemistry analysis showed that HAP1-A and 
HAP1-B overexpression prevents the OGD-induced reduction of GABAAR β3 subunit surface 
levels (Figure 3.10 A), as well as the reduction in GABAAR β3 recycling under the same conditions 
(Figure 3.10 B). These results indicate that HAP1 overexpression is capable of rescuing the levels 
of surface GABAAR β3 subunit during OGD, possibly by improving its recycling 
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Figure 3.10. Overexpression of HAP1 protein abrogates the effect of OGD on GABAAR β3 
subunit recycling. 
(A-A’) Cultured hippocampal neurons were transfected with myc-tagged GABAAR β3 subunit, 
together with GFP-tagged HAP1A, GFP-tagged HAP1B or EGFP, and subjected to OGD (90 min). 
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The effect of OGD on the surface expression of the myc-tagged GABAAR β3 subunits was 
evaluated in the neuritic compartments by immunocytochemistry, with an anti-myc antibody, under 
non-permeabilizing conditions. (B-B’) Receptor recycling was assessed using an antibody-feeding 
assay and analyzed by fluorescence microscopy in cells labelled with anti-myc (N-terminus). After 
quantification of the immunoreactivity in the neuritic compartments, the results were expressed as a 
ratio of reclycled receptors/total receptor immunoreactivity and as percentage of control. The results 
were normalized and presented as percentage of the control. The results are the mean ± SEM of 3 
independent experiments, performed in different preparations. Statistical analysis was performed by 
one-way ANOVA, followed by Dunett and Bonferroni’s test. *p<0.05 - significantly different when 
compared to the respective control condition. Non-significant (ns) differences were observed for the 
indicated comparisons. 
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DISCUSSION AND CONLUSIONS 
Huntingtin-associated protein 1 (HAP1), originally identified as a neuronal protein that 
interacts with the Huntington disease (HD) protein, huntingtin (htt), plays a critical role in 
the trafficking of intracellular organelles and membrane proteins by interacting with a 
number of proteins (Li et al. 1998b; Li et al. 1995; Martin et al. 1999; Engelender et al. 
1997). Among these, HAP1 binds the GABAAR β subunit regulating its trafficking (Kittler 
et al. 2004). GABAAR regulate neuronal excitability depending of their cell surface 
availability and stability. During GABAAR cell trafficking, HAP1 inhibits the receptor 
lysosomal degradation and facilitates its recycling back to the plasma membrane (Kittler et 
al. 2004). Accordingly, overexpression of HAP1 increases GABAAR cell surface number 
and decrease neuronal excitability (Kittler et al. 2004). Disruption of GABAAR trafficking 
alters the balance between excitatory and inhibitory neurotransmission in the brain, 
contributing to pathological processing in conditions such as epilepsy and ischemia, which 
are characterized by an acute receptor surface downmodulation and loss of synaptic 
GABAAR. HAP1 is emerging as an important regulator of GABAAR membrane expression 
and as a possible target for future therapeutic strategies in cerebral ischemia treatment. 
Considering the results previously obtained in our laboratory showing a reduction in 
GABAAR recycling rate, as well as a decrease in GABAAR/HAP1 interaction, in 
hippocampal neurons subjected to OGD, in the present work we aimed at investigating the 
effect of cerebral ischemia on HAP1 receptor expression and its contribution to the 
alteration of GABAAR trafficking observed in OGD. Our results show a downregulation of 
HAP1 in hippocampal and cortical neurons subjected to OGD, and the provide evidence for 
the role of the protein in the regulation of GABAAR surface expression and intracellular 
traffic under ischemic conditions. 
Exposure of hippocampal neurons to 90 min of OGD, an experimental condition that 
induces the death of about ~35% of the neurons (Mele et al. 2014), reduced the expression 
of HAP1 protein when tested 2 h after the stimulus, and this effect was maintained during 
the re-oxygenation period for up to 8 h. Since the downregulation of the protein was only 
observed at 2 h after OGD it is unlikely to account for the decrease in the interaction 
between GABAAR β3 and HAP1 observed in hippocampal neurons immediately after the 
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ischemic insult (Mele et al. 2014). Therefore, these results suggest that the downmodulation 
of HAP1 is not the initial cause of GABAAR β3 recycling impairment but is rather a factor 
that can exacerbate the reduction of surface GABAAR expression. Accordingly, we 
observed a protective effect of HAP1 overexpression on the OGD-induced reduction of 
membrane GABAAR β3 subunits, as shown by live staining of GABAAR β3 subunits in 
hippocampal neurons subjected to OGD (90 min). Moreover using the antibody feeding 
assay we demonstrate that HAP1 overexpression also rescued hippocampal neurons from 
the impairment of GABAAR recycling.  
The regulation of the GABAAR/HAP1 interaction is crucial for the alteration of GABAAR 
trafficking observed in cerebral ischemia (Mele et al. 2014). HAP1 interacts with a region 
in the intracellular domain of GABAAR β subunit through an amino acid sequence of its 
central domain (residues 220-520), but the molecular mechanisms involved in this 
interaction were not characterized. HAP1 phosphorylation may play a role in the 
modulation of GABAAR/HAP1 interaction. In fact, this post-translational modification has 
an important role in regulating HAP1 binding with some microtubule-associated proteins 
involved in retrograde and anterograde transport, such as p150Glued and kinesin light chain 
(Aniento et al. 1993; Lin et al. 2002). Our results indicate that protein phosphorylation 
(possibly HAP1 phosphorylation) is also involved in the control of total HAP1 protein 
levels in hippocampal neurons, both under control conditions and following transient OGD. 
Incubation of hippocampal neurons with the PP1 and PP2A inhibitor okadaic acid 
significantly upregulated HAP1 protein levels under control conditions, and this effect may 
account, at least in part, for the preservation of HAP1 protein levels, as compared with the 
control conditions, when hippocampal neurons were subjected to transient OGD. In 
contrast, although calcineurin inhibition slightly increased HAP1 protein levels under 
control conditions, it was without effect on the downregulation of the protein after transient 
OGD. Taken together, these results suggest that: i) PP1/PP2A and calcineurin phosphatases 
contribute to the maintenance of physiological levels of HAP1, and ii) PP1/PP2A inhibition 
prevents the OGD-induced downregulation of HAP1, possibly by stabilizing the protein in 
the cells. These results are in agreement with the observed increase of HAP1 levels 
following stimulation of hypothalamic cultured neurons with PP1/PP2A phosphatase 
inhibitor (okadaic acid) (Rong et al. 2006). On the other hand, PKA and PKC activation did 
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not alter HAP1 levels both in control and OGD condition, suggesting a specific role of 
phosphatases in this process. Alternatively, other protein kinases may be involved in the 
regulation of HAP1 protein levels. Furthermore, the decrease in ATP levels following OGD 
(Choi 1996) may also impair protein kinase activity. 
Inhibition of calpains with MDL28170 was found to prevent OGD-induced downregulation 
of HAP1, showing a role for these Ca
2+
-dependent proteases in HAP1 degradation after 
OGD. The upregulation of calpain activity under excitotoxic conditions and in brain 
ischemia is also coupled to an abnormal cleavage and/or degradation of several other 
proteins (Gomes et al. 2012; Gomes et al. 2011; Mele et al. 2014; Lobo et al. 2011). 
Surprisingly these results were not confirmed in the MCAO in vitro model of ischemia, 
where an increased HAP1 protein expression was observed in the cerebral area 
corresponding to ischemic core. We hypothesized two possible reasons for this discrepancy. 
First, the OGD in vitro model of ischemia was performed using cultured hippocampal 
neurons while the ischemic core of MCAO is located in the cerebral cortex; therefore, there 
is a difference between the cell types subjected to the insult in the two models. The second 
hypothesis is related to the presence of glial cells in the cerebral tissue (that is the case of 
MCAO samples), which are not represented in the hippocampal cultures used for OGD. 
The results showing i) an upregulation of HAP1 in cultured glial cells following OGD and 
ii) the decrease in HAP1 protein levels in cultured cortical neurons subjected to OGD, 
similarly to the results obtained in hippocampal neurons, favour the second hypothesis.  
To further investigate the effect of OGD on HAP1 protein in glial cells we analysed the 
alterations in the mRNA levels to determine the role of transcription regulation in the 
process. Quantitative PCR data from glial cells subjected to OGD showed a small but not 
significant decrease of HAP1-mRNA levels, showing that the alteration of HAP1 protein 
levels in glial cells during OGD are not correlated with modifications at transcriptional 
level. However, since the alterations in mRNA are normally faster and precede the changes 
in protein expression, the results obtained from mRNA analyses in glial cells 12 h after 
OGD may be related to the decrease of HAP1 protein observed 24 h after the ischemic 
insult and that is exacerbated at 48 h.  
The present study also showed for the first time the presence of HAP1 in glial cells. 
Previous studies suggested the absence of the protein in glial cells, as shown both with 
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western blot analysis in mature astrocytes obtained from cultured mouse neurospheres 
(Xiang et al. 2014) and with immunolabeling cerebral slices (Gutekunst et al. 1998). 
However, and in contrast with these observations we demonstrated by western blot analysis 
and with qPCR, the expression of this protein and the correspondent mRNA in glial cells as 
well as in mature astrocytes. 
 
Taken together our results indicate that ischemic condition down-modulates HAP1 protein 
by a calpain-dependent mechanism, and a role for protein phosphatases-1/-2A in the 
regulation of HAP1 protein stability was also identified. Moreover, in this work was 
uncovered a novel role for HAP1 protein in the regulation of GABAAR trafficking during 
cerebral ischemia. Considering the protective effect of GABAAR surface stabilization 
against ischemic-induced neuronal death (Smith et al. 2012; Mele et al. 2014), HAP1 may 
constitute an important therapeutic target for cerebral ischemia.  
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